Market News & Trends
Intellia Therapeutics Demonstrates Pioneering CRISPR/Cas9 Genome Editing Efficiency Data Using Lipid Nanoparticle Delivery Technology
Intellia Therapeutics, Inc., a leading genome editing company focused on the development of potentially curative therapies, recently reported updated data showing increased levels of genome…
New Data Demonstrate Sandoz Proposed Biosimilar Has Equivalent Efficacy
Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, recently presented data for its proposed biosimilar adalimumab (GP2017). The Phase III confirmatory…
Esperion Announces Initiation of Phase II Triplet Oral Therapy Study
Esperion Therapeutics, Inc., the lipid management company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated…
AB BioTechnologies Selects Vanrx Pharmasystems Aseptic Filling & Lyophilizer Loading Workcells
AB BioTechnologies (AB), a provider of contract development and manufacturing services for the pharmaceutical industry, has selected Vanrx Pharmasystems to provide aseptic filling and lyophilizer…
Pfizer CentreOne Adds Highly Potent Solid Oral Dose to its Service Portfolio
Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, recently announced that it has grown its service portfolio to include contract manufacturing of…
Pfizer CentreOne Adds Highly Potent Solid Oral Dose to its Service Portfolio
Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, recently announced that it has grown its service portfolio to include contract manufacturing of…
ABITEC Corporation & IMCD Announce Specialty Lipid Distribution Agreement
US ingredients conglomerate announces new partnership to distribute specialty lipids into the pharmaceutical and nutritional markets in Asia and South America. ABITEC Corporation has…
Avomeen Analytical Services Announces New CEO
Avomeen Analytical Services, a full-service independent analytical testing and product development laboratory based in Ann Arbor, MI, recently announced that Mark Harvill has been named…
ABITEC Corporation & IMCD Announce Specialty Lipid Distribution Agreement
US ingredients conglomerate announces new partnership to distribute specialty lipids into the pharmaceutical and nutritional markets in Asia and South America. ABITEC Corporation has…
$100 Billion of Revenues up for Grabs for Drug Manufacturers by 2020 as Patents for Key Biologics Expire
Although complexities inherent in biological drug manufacturing are creating barriers for further expansion of the biosimilars market, imminent patent expiries of key biologics are set…
$100 Billion of Revenues up for Grabs for Drug Manufacturers by 2020 as Patents for Key Biologics Expire
Although complexities inherent in biological drug manufacturing are creating barriers for further expansion of the biosimilars market, imminent patent expiries of key biologics are set…
Ompi EZ-Fill Becomes an Internationally Recognized Standard Platform for RTU Sterile Containers
Ompi, the company within Stevanato Group specialized in glass primary packaging for the pharmaceutical industry, has signed a license agreement with Gerresheimer. The agreement…
Ompi EZ-Fill Becomes an Internationally Recognized Standard Platform for RTU Sterile Containers
Ompi, the company within Stevanato Group specialized in glass primary packaging for the pharmaceutical industry, has signed a license agreement with Gerresheimer. The agreement…
Accelerating Development of Enabled Formulations for Poorly Soluble Drugs
Efficacy issues due to inadequate gastrointestinal (GI) absorption caused by insufficient aqueous solubility are encountered in up to 70% of new drugs in development. Often…
Capnia Completes Merger With Essentialis, Creating Rare Disease Therapeutics Company
Capnia, Inc., focused on the development and commercialization of novel therapeutics for the treatment of rare diseases, recently announced it has completed its previously announced…
Head & Neck Cancer Market Offers Fertile Investment Ground as Disease Understanding Improves
A substantial number of first-in-class products in the head and neck cancer pipeline will reach the market over the coming decade, potentially transforming the clinical…
Accelerating Development of Enabled Formulations for Poorly Soluble Drugs
Efficacy issues due to inadequate gastrointestinal (GI) absorption caused by insufficient aqueous solubility are encountered in up to 70% of new drugs in development. Often…
Capnia Completes Merger With Essentialis, Creating Rare Disease Therapeutics Company
Capnia, Inc., focused on the development and commercialization of novel therapeutics for the treatment of rare diseases, recently announced it has completed its previously announced…
Head & Neck Cancer Market Offers Fertile Investment Ground as Disease Understanding Improves
A substantial number of first-in-class products in the head and neck cancer pipeline will reach the market over the coming decade, potentially transforming the clinical…
Kitov Announces License Agreement for KIT-302 in South Korea
Kitov Pharmaceuticals Holdings Ltd., an innovative biopharmaceutical company, recently announced it has signed a definitive License Agreement for its lead product candidate, KIT-302, which was…
